WELCOME TO THE NONPROFIT REPORT
Newsletter | Member Login | Signup
Home > Companies > Dallas Area Habitat for Humanity
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Webinar
Nonprofit Technology
United Health Foundation | March 07, 2022
The United Health Foundation, the philanthropic foundation of UnitedHealth Group, announced a $1 million donation to support relief efforts in Ukraine. The donation includes: $500,000 to Save the Children, the U.S. affiliate of Save the Children International, to support its Ukraine Crisis Relief Fund to provide children and families with immediate aid such as food, water, hygiene kits and psychosocial support. $500,0000 to Di...
Fundraising
Green Apple | October 30, 2020
The Green Apple Pay nonprofit fundraising platform is launching in early November and will be available Canada wide. This platform acts as the keystone in fundraising efforts for organizations and their stakeholders. By providing digital tools and functionality, Green Apple Pay makes it easy to generate automated and recurring revenues from micro-donations and affinity commissions. Stakeholders only need to sign up once and never have to do anything after that to keep supporting the organization...
GoFundMe | May 19, 2022
GoFundMe, the trusted leader in online fundraising, announced that Margaret Richardson has joined the company as its Chief Corporate Affairs Officer. She will be responsible for building and leading GoFundMe’s corporate affairs team consisting of government relations, public policy, and corporate communications. Richardson will join the company’s executive team, reporting to and working closely with CEO Tim Cadogan. Richardson has decades of experience in both the publ...
GSK | January 27, 2020
GlaxoSmithKline has licensed a tuberculosis vaccine to the Bill & Melinda Gates Medical Research Institute (MRI). The deal sets the stage for a push to build on recent phase 2b data and make the vaccine available in low-income countries where TB is prevalent. The vaccine, M72/AS01E, is made up of an immunogenic fusion protein based on two TB antigens. GSK combined that protein with the adjuvant found in its shingles prophylactic Shingrix to create a subunit vaccine. Last year, a phase 2b tri...
Article
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE